Blog Article

Congratulations to the University of Washington’s Dr. John Gore and Dr. Angela Smith from the University of North Carolina, along with a team of researchers… Read more

Bethesda, Maryland – The Bladder Cancer Advocacy Network (BCAN) would like to thank Senators Bob Menendez (D-NJ) and Johnny Isakson (R-GA), as well as every… Read more

How does immunotherapy work?  Peter H. O’Donnell, MD, from The University of Chicago, Section of Hematology/Oncology, explains immunotherapy as a bladder cancer treatment and addresses… Read more

Leading bladder cancer experts have provided a more in-depth look at topics in which patients have expressed a greater interest.  Additional topics will be coming… Read more

February 16, 2018– Today Photocure ASA announced the FDA approval of new indications for Blue Light Cystoscopy (BLC™) with Cysview®.  This supplemental new drug application… Read more

Amsterdam, NL and Bethesda, US – IOS Press, an international scientific, technical and medical publisher, and the Bladder Cancer Advocacy Network (BCAN), are pleased to… Read more

With no new bladder cancer treatment approvals in 30 years, 2016 proved to be a breakthrough year in bladder cancer research.  It kicked off this… Read more

Following a bladder cancer diagnosis in 2007, David Pulver went for a second opinion to Dr. Mark Schoenberg, a renowned urologist and expert in the… Read more

What is bladder cancer? Bladder cancer is the nation’s sixth most common form of cancer with more than 81,000 new cases and over 17,000 deaths each year. … Read more